Zhou F. · Sun J. · Chen X. · Sun G. · Jin B.

Author affiliations

Department of Urology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: April 20, 2022
Accepted: June 22, 2022
Published online: October 11, 2022

Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 1

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Abstract

Primary adrenal teratoma is a rare lesion with a high misdiagnosis rate. In view of the fact that adrenal teratoma and adrenal gland are often inseparable, the removal of the affected adrenal gland seems inevitable. Thus, it is necessary for clinicians to differentiate adrenal teratoma from common adrenal lipoma diseases, such as adrenal angiomyolipoma, adrenal myelolipoma, lipoma, gangliocytoma, and so on. In this study, we reported the clinical and pathologic features of 7 patients surgically treated for adrenal mature teratomas from 2007 to 2020 in our hospital. We compared the clinical characteristics and surgical management in literature review cases with our cases. All patients were females and underwent open adrenalectomy or laparoscopic adrenalectomy, respectively. In our cases, there was no recurrence during the longest follow-up of 13 years. Adrenal teratoma is rare and easy to ignore. And once misdiagnosed, the surgeon may need to adjust the operation temporarily, extend the operation time and finally increase the operative risks. Our aim is mainly to help clinicians to raise awareness of adrenal teratomas, improve the diagnosis rates and optimize the treatment decision-making of this disease.

© 2022 S. Karger AG, Basel

References Lam KY, Lo CY. Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution. J Clin Pathol. 2001 Sep;54(9):707–12. Khong PL, Lam KY, Ooi CGC, Liu MJ, Metreweli C. Mature teratomas of the adrenal gland: imaging features. Abdom Imag. 2002 May–Jun;27(3):347–50. Asano T, Kawakami S, Okuno T, Tsujii T, Nemoto T, Kageyama Y, et al. Malignant transformation in a mature testicular teratoma left untreated for more than 50 years since childhood. Scand J Urol Nephrol. 2003;37(2):177–8. Bhatia V, Sharma S, Sood S, Mardi K, Venkat B. Case 231: retroperitoneal adrenal teratoma presenting as trichoptysis. Radiology. 2016 Jul;280(1):317–21. Kataoka M, Fukushima H, Nakanishi Y, Yokoyama M, Funata N, Motoi T, et al. Retroperitoneal teratoma in an adult: a potential pitfall in the differential diagnosis of adrenal myelolipoma. Case Rep Urol. 2016;2016:5141769. Kuo EJ, Sisk AE, Yang Z, Huang J, Yeh MW, Livhits MJ. Adrenal teratoma: a case series and review of the literature. Endocr Pathol. 2017 Jun;28(2):152–8. Maenosono R, Saito K, Ibuki N, Takahara K, Inamoto T, Nomi H, et al. A case of retroperitoneal teratoma difficult to distinguish from adrenal tumor. Hinyokika Kiyo. 2017 Dec;63(12):525–8. Niu M, Liu A, Zhao Y, Feng L. Malignant transformation of a mature teratoma of the adrenal gland: a rare case report and literature review. Medicine. 2017 Nov;96(45):e8333. Ramakant P, Rana C, Singh KR, Mishra A. Primary adrenal teratoma: an unusual tumor - challenges in diagnosis and surgical management. J Postgrad Med. 2018 Apr–Jun;64(2):112–4. Zhou L, Pan X, He T, Lai Y, Li W, Hu Y, et al. Primary adrenal teratoma: a case series and review of the literature. Mol Clin Oncol. 2018 Oct;9(4):437–42. Sharma S, Dawson L, Mandal AK. Primary retroperitoneal teratoma with predominant neurogenic elements masquerading as adrenal tumor. Turk Patoloji Derg. 2019;35(1):69–73. Zhong W, Ma R, Cheng S, Tian J, Wang H, Wang T, et al. Clinical characteristics and surgical management of adult adrenal teratoma: a 15-year experience and systematic review of the literature. Urology. 2020 Jan;135:71–5. Lam KY, Lo CY. Teratoma in the region of adrenal gland: a unique entity masquerading as lipomatous adrenal tumor. Surgery. 1999 Jul;126(1):90–4. Goyal M, Sharma R, Sawhney P, Sharma MC, Berry M. The unusual imaging appearance of primary retroperitoneal teratoma: report of a case. Surg Today. 1997;27(3):282–4. Bedri S, Erfanian K, Schwaitzberg S, Tischler AS. Mature cystic teratoma involving adrenal gland. Endocr Pathol. 2002 Spring;13(1):59–64. Article / Publication Details

First-Page Preview

Received: April 20, 2022
Accepted: June 22, 2022
Published online: October 11, 2022

Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 1

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.